Boothbay Fund Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,477
| Closed | -$41K | – | 1709 |
|
|
2024
Q4 | $41K | Buy |
+13,477
| New | +$41K | ﹤0.01% | 1219 |
|
|
2022
Q4 | – | Sell |
-20,619
| Closed | -$557K | – | 2208 |
|
|
2022
Q3 | $557K | Buy |
+20,619
| New | +$557K | 0.01% | 1022 |
|
|
2021
Q4 | – | Sell |
-8,355
| Closed | -$233K | – | 2067 |
|
|
2021
Q3 | $233K | Sell |
8,355
-873
| -9% | -$24.3K | 0.01% | 1248 |
|
|
2021
Q2 | $274K | Buy |
+9,228
| New | +$274K | 0.01% | 1183 |
|
|
2020
Q4 | – | Sell |
-15,718
| Closed | -$395K | – | 1318 |
|
|
2020
Q3 | $395K | Sell |
15,718
-3,462
| -18% | -$87K | 0.02% | 620 |
|
|
2020
Q2 | $468K | Sell |
19,180
-4,720
| -20% | -$115K | 0.03% | 506 |
|
|
2020
Q1 | $354K | Sell |
23,900
-19,300
| -45% | -$286K | 0.03% | 447 |
|
|
2019
Q4 | $701K | Buy |
+43,200
| New | +$701K | 0.06% | 336 |
|
|
2018
Q2 | – | Sell |
-10,878
| Closed | -$335K | – | 818 |
|
|
2018
Q1 | $335K | Buy |
+10,878
| New | +$335K | 0.04% | 330 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 763 |
|